His primary areas of investigation include Surgery, Carcinoma, Cancer, Internal medicine and Radiation therapy. His Surgery research is multidisciplinary, incorporating perspectives in Epidermoid carcinoma and Neck dissection. His Carcinoma research is multidisciplinary, relying on both Metastasis, Thyroid, Univariate analysis and Adenocarcinoma.
His Cancer research includes themes of Radiology, Mucosal melanoma and Incidence. Jatin P. Shah has included themes like Gastroenterology and Oncology in his Internal medicine study. His Radiation therapy research incorporates themes from Laryngectomy and Salvage therapy, Chemotherapy.
Jatin P. Shah mainly focuses on Surgery, Internal medicine, Cancer, Oncology and Radiation therapy. His work deals with themes such as Carcinoma and Neck dissection, which intersect with Surgery. His Carcinoma study integrates concerns from other disciplines, such as Survival analysis, Metastasis and Thyroid, Thyroid cancer.
His work on Multiple myeloma, Dexamethasone and Bortezomib as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His research integrates issues of Stage, Radiology, Incidence and Disease in his study of Cancer. The Radiation therapy study combines topics in areas such as Larynx and Chemotherapy.
Jatin P. Shah spends much of his time researching Internal medicine, Oncology, Cancer, Multiple myeloma and Dexamethasone. The Internal medicine study which covers Gastroenterology that intersects with Incidence, Salivary gland and Survival rate. His Oncology research includes elements of Stage, Relapsed refractory, Cohort and Lymphoma.
The various areas that Jatin P. Shah examines in his Cancer study include Surgery, Radiation therapy, Radiology and Retrospective cohort study. As part of one scientific family, Jatin P. Shah deals mainly with the area of Surgery, narrowing it down to issues related to the Thyroid, and often Lymph node. His Radiation therapy research is multidisciplinary, incorporating elements of Neck dissection, Chemotherapy and Dentistry.
His main research concerns Internal medicine, Cancer, Oncology, Head and neck cancer and Radiation therapy. As a part of the same scientific family, Jatin P. Shah mostly works in the field of Internal medicine, focusing on Gastroenterology and, on occasion, Clinical endpoint. His work on Perineural invasion, Mouth neoplasm and Oral Cavity Squamous Cell Carcinoma as part of general Cancer research is frequently linked to In patient, bridging the gap between disciplines.
His Radiation therapy research includes elements of Neck dissection, Dentistry and Cohort. His Salvage surgery research is included under the broader classification of Surgery. Jatin P. Shah performs multidisciplinary study on Surgery and Head in his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Head and Neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
William M. Lydiatt;Snehal G. Patel;Brian O'Sullivan;Margaret S. Brandwein.
CA: A Cancer Journal for Clinicians (2017)
Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract
Jatin P. Shah.
American Journal of Surgery (1990)
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Georgette Chan;Jay O. Boyle;Eun K. Yang;Fan Zhang.
Cancer Research (1999)
Current concepts in management of oral cancer – Surgery
Jatin P. Shah;Ziv Gil.
Oral Oncology (2009)
The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity.
Jatin P. Shah;Frank C. Candela;Anil K. Poddar.
Cancer (1990)
Papillary carcinoma of the thyroid
H.Randall Tollefsen;Jatin P. Shah;Andrew G. Huvos.
American Journal of Surgery (1963)
Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996: An American college of surgeons commission on cancer patient care evaluation study
Scott A. Hundahl;Blake Cady;Myles P. Cunningham;Ernest Mazzaferri.
Cancer (2000)
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.
R. Michael Tuttle;Hernan Tala;Jatin Shah;Rebecca Leboeuf.
Thyroid (2010)
Head and Neck Cancers, Version 2.2014
David G. Pfister;Sharon Spencer;David M. Brizel;Barbara Burtness.
Journal of The National Comprehensive Cancer Network (2014)
Prognostic factors in differentiated carcinoma of the thyroid gland.
Jatin P. Shah;Thom R. Loree;Digpal Dharker;Elliot W. Strong.
American Journal of Surgery (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Northwell Health
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Indiana University
New York University
ETH Zurich
Shanghai Jiao Tong University
JSR (Japan)
Dalian University of Technology
Ben-Gurion University of the Negev
Washington State University
Shizuoka University
Environmental Protection Agency
Utrecht University
Cleveland Clinic
Rockefeller University
Royal College of Music
University of Tromsø - The Arctic University of Norway
University of the Witwatersrand